Back to top

Director Makes Strategic Move with NewAmsterdam Pharma Stock Purchase

New insider activity at NewAmsterdam Pharma Company ( ($NAMS) ) has taken place on September 17, 2025. Director James Topper has made a significant...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

NewAmsterdam Pharma Company N.V. (NAMS)